Michihito Onishi
Directeur/Membre du Conseil chez HISHOH Biopharma Co., Ltd.
Provenance du réseau au premier degré de Michihito Onishi
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
HISHOH Biopharma Co., Ltd.
 HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Michihito Onishi via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Cellusion Inc.
 Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Miscellaneous Commercial Services | Director/Board Member | |
| Wake Forest University | College/University | Doctorate Degree |
Statistiques
Internationale
| Japon | 2 |
| Etats-Unis | 2 |
Sectorielle
| Commercial Services | 2 |
| Consumer Services | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Toru Seo | 3 |
| Naoki Sakurai | 1 |
- Bourse
- Insiders
- Michihito Onishi
- Connexions Sociétés
